Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Ala Scalp
Overview
What is Ala Scalp?
The topical corticosteroids constitute a class of primarily synthetic steroids used a anti-inflammatory and antipruritic agents. Hydrocortisone is a member of this class. Chemically hydrocortisone is pregn-4-ene-3, 20-dione, 11, 17, 21-trihydroxy, (11ß)-. Its structural formula is:
Each mL of ALA-SCALP
(Hydrocortisone Lotion USP, 2%) contains 20 mg hydrocortisone USP in a vehicle of isopropyl alcohol, polysorbate 20, purified water, propylene glycol, polysorbate 20, and benzalkonium chloride.
What does Ala Scalp look like?
What are the available doses of Ala Scalp?
Sorry No records found.
What should I talk to my health care provider before I take Ala Scalp?
Sorry No records found
How should I use Ala Scalp?
Hydrocortisone Lotion is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
What interacts with Ala Scalp?
Hydrocortisone Lotion is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
What are the warnings of Ala Scalp?
Sorry No Records found
What are the precautions of Ala Scalp?
General
Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings.
Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid.
Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. Infrequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids.
Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity (See).
If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.
In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.
What are the side effects of Ala Scalp?
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: b
To report SUSPECTED ADVERSE REACTIONS, contact Crown Laboratories, Inc. at 1-866-400-7546 or FDA at 1-800-FDA-1088 or https://www.fda.gov/Safety/MedWatch/
What should I look out for while using Ala Scalp?
Hydrocortisone Lotion is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
What might happen if I take too much Ala Scalp?
Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (See ).
How should I store and handle Ala Scalp?
Storage and HandlingStore at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) (see USP Controlled Room Temperature).Storage and HandlingStore at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) (see USP Controlled Room Temperature).ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02ALA-SCALP (Hydrocortisone Lotion USP, 2%) is supplied in:1 FL OZ (29.6 mL) NDC 0316-0140-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Manufactured and Distributed by:Crown Laboratories, Inc.Johnson City, TN, 37604PRINTED IN USAREVISED: MAY 2017P8003.02
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions.The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.
Non-Clinical Toxicology
Hydrocortisone Lotion is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.Drug Interactions
Acidifying Agents
Adrenergic Blockers
Alkalinizing Agents
MAO Inhibitors
Antihistamines
Antihypertensives
Chlorpromazine
Ethosuximide
Haloperidol
Lithium Carbonate
Meperidine
Methenamine Therapy
Norepinephrine
Phenobarbital
Phenytoin
Propoxyphene
Veratrum Alkaloids
General
Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings.
Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid.
Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. Infrequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids.
Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity (See).
If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.
In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: b
To report SUSPECTED ADVERSE REACTIONS, contact Crown Laboratories, Inc. at 1-866-400-7546 or FDA at 1-800-FDA-1088 or https://www.fda.gov/Safety/MedWatch/
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Read user comments about the side effects, benefits, and effectiveness of losartan oral.
Overall User Ratings
516Total User Reviews
User Reviews
Learn about
User Reviews
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).